NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 836 / 982

  1. Facilitation of Fear Extinction by D-Cycloserine: Theoretical and Clinical Implications2004 · OpenAlex
  2. Factors affecting the formation of acrylamide in coffee2004 · Crossref
  3. Factors Associated with Criminal Severity among Adolescents Entering Substance Abuse Treatment2004 · Crossref
  4. Factors Associated with Readiness to Stop Smoking among Patients in Treatment for Alcohol Use Disorder2004 · Crossref
  5. Factors associated with sex trade involvement among male participants in a prospective study of injection drug users2004 · OpenAlex
  6. Family Environment Factors and Substance Abuse Severity in an HMO Adolescent Treatment Population2004 · Crossref
  7. Family Therapy Theory Applied in a Group Setting: The Family Issues Group2004 · Crossref
  8. Family‐based therapies for adolescent alcohol and drug use: research contributions and future research needs2004 · Crossref
  9. Fatal Intravenous Fentanyl Abuse2004 · OpenAlex
  10. Fetal alcohol syndrome at the cellular level2004 · Crossref
  11. Fetal alcohol syndrome in the United States corrections system2004 · Crossref
  12. Fetal alcohol syndrome prevention in Washington State: evidence of success2004 · Crossref
  13. Fetal alcohol syndrome through the eyes of parents2004 · Crossref
  14. Fetal alcohol syndrome: Diagnosis, epidemiology, and developmental outcomes2004 · Crossref
  15. Finding a place for needle exchange programs2004 · OpenAlex
  16. Finnish Newspapers' Positions on Drug Policy between 1993 and 20002004 · Crossref
  17. Firm Organization and the Structure of Retail Markets2004 · Crossref
  18. First and second generation generic Indians on drug use: using cultural norms and yoga in drug prevention2004 · Crossref
  19. Five‐year alcohol and drug treatment outcomes of older adults versus middle‐aged and younger adults in a managed care program2004 · Crossref
  20. Flavonoids as Chemotaxonomic Markers for Erythroxylum australe2004 · Crossref
  21. Fluoxetine therapy in depersonalisation disorder: Randomised controlled trial2004 · OpenAlex
  22. Forecasting the spot prices of various coffee types using linear and non‐linear error correction models2004 · Crossref
  23. Fourteen to 17‐year‐olds' experience of ‘risky’ drinking—a cross‐sectional survey undertaken in south‐east England2004 · Crossref
  24. Fragmentation patterns of selected ergot alkaloids by electrospray ionization tandem quadrupole mass spectrometry2004 · Crossref
  25. Friends Don't Let Friends … or do They? Developmental and Gender Differences in Intervening in Friends' Atod Use2004 · Crossref
  26. From child sexual abuse to adult sexual risk: Trauma, revictimization, and intervention.2004 · OpenAlex
  27. From Chivalrous ‘Brothers-in-Arms’ to the Eligible Athlete2004 · Crossref
  28. From Delirium to Coherence: Shamanism and Medicine Plants in Silko’s Ceremony2004 · OpenAlex
  29. From the swamp to the terrace: intensification of horticultural practices in New Caledonia, from first settlement to European contact2004 · OpenAlex
  30. Functional Characterization of Enzymes Forming Volatile Esters from Strawberry and Banana2004 · OpenAlex
  31. Further Evidence on the Labor Market Effects of Addiction: Chronic Drug Use and Employment in Metropolitan Miami2004 · Crossref
  32. G protein activation and cyclic AMP modulation by naloxone benzoylhydrazone in distinct layers of rat olfactory bulb2004 · Crossref
  33. Gambling: The Hidden Addiction2004 · OpenAlex
  34. Gamma hydroxybutirate use for sexual assault2004 · OpenAlex
  35. Gas chromatographic determination of cocaine and its metabolites in blood and urine from cocaine users in northwestern Spain2004 · Crossref
  36. Gender convergence in alcohol consumption and related problems: issues and outcomes from comparisons of New Zealand survey data2004 · Crossref
  37. Gender Differences in Substance Use Treatment Entry and Retention Among Prisoners With Substance Use Histories2004 · Crossref
  38. Gender Differences in Treatment Outcomes over a Three-Year Period: A Path Model Analysis2004 · Crossref
  39. General and Specific Predictors of Behavioral and Emotional Problems Among Adolescents2004 · Crossref
  40. GENERAL STRAIN, STREET YOUTH AND CRIME: A TEST OF AGNEW'S REVISED THEORY*2004 · Crossref
  41. Generation and characterization of ionic and neutral methylene isothiocyanate by a combined tandem mass spectrometry and computational study2004 · Crossref
  42. Genet size and distribution of Amanita muscaria in a suburban park, Dunedin, New Zealand2004 · OpenAlex
  43. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice.2004 · PubMed
  44. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke–induced emphysema in mice2004 · OpenAlex
  45. Genetic effects on alcohol dependence risk: re-evaluating the importance of psychiatric and other heritable risk factors2004 · OpenAlex
  46. Genetic fingerprinting of Fijian kava2004 · Crossref
  47. Genetic studies and their implication to breed desired plant type in opium poppy, Papaver somniferum L.2004 · Crossref
  48. Genetic study of alcoholism and novel gene expression in the alcoholic brain2004 · Crossref
  49. Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers2004 · OpenAlex
  50. Genotoxic and Antiapoptotic Effect of Nicotine on Human Gingival Fibroblasts2004 · OpenAlex
  51. Gestalt Therapy: A Harm Reduction Approach2004 · Crossref
  52. Globalization, differentiation and drinking cultures, an anthropological perspective2004 · Crossref
  53. Glosario2004 · OpenAlex
  54. GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales2004 · Crossref
  55. Grey Lungs and Blue Moods: Smoking Cessation in the Context of Lifetime Depression History2004 · Crossref
  56. Group I Metabotropic Glutamate Receptor NMDA Receptor Coupling and Signaling Cascade Mediate Spinal Dorsal Horn NMDA Receptor 2B Tyrosine Phosphorylation Associated with Inflammatory Hyperalgesia2004 · OpenAlex
  57. Group Therapy for Substance Use Disorders: What Do We Know?2004 · OpenAlex
  58. Guilt, Fear, Stigma and Knowledge Gaps: Ethical Issues in Public Health Communication Interventions2004 · Crossref
  59. Habitual self‐mutilation in Japan2004 · OpenAlex
  60. Hair testing and self‐report of cocaine use by heroin users2004 · OpenAlex
  61. Hair‐testing for illicit drugs2004 · Crossref
  62. Hallucinogens and dissociative agents naturally growing in the United States.2004 · PubMed
  63. Hallucinogens.2004 · PubMed
  64. Harm minimization in school drug education: final results of the School Health and Alcohol Harm Reduction Project (SHAHRP)2004 · Crossref
  65. Harm reduction and the global drug control regime: contemporary problems and future prospects*2004 · Crossref
  66. Harm Reduction Approaches to Reducing Tobacco-Related Mortality2004 · Crossref
  67. Harm Reduction for the Prevention of Youth Gambling Problems2004 · Crossref
  68. Harm reduction in prisons: a ‘rights based analysis’2004 · OpenAlex
  69. Health Risk Behavior Assessment: Nutrition, Weight, and Tobacco Use in One Urban Seventh‐Grade Class2004 · Crossref
  70. Healthy living in hard times2004 · OpenAlex
  71. Hedging their bets: tobacco and gambling industries work against smoke-free policies2004 · Crossref
  72. Hemispheric Asymmetry in Stress Processing in Rat Prefrontal Cortex and the Role of Mesocortical Dopamine2004 · OpenAlex
  73. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty2004 · Crossref
  74. Hepatitis C in Patients with Co‐occurring Mental Disorders and Substance Use Disorders: Is Tobacco Use a Possible Risk Factor?2004 · Crossref
  75. Herbal mind altering substances: an unknown quantity?2004 · OpenAlex
  76. Herbal remedies in the United States: potential adverse interactions with anticancer agents.2004 · PubMed
  77. Hero or Hypocrite?2004 · Crossref
  78. Hero-Ego in Search of Self: A Jungian Reading of Beowulf by Judy Anne White (review)2004 · OpenAlex
  79. Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non‐drug‐using controls2004 · OpenAlex
  80. Heroin and diplopia2004 · Crossref
  81. Heroin diffusion in the mid‐Hudson region of New York State2004 · Crossref
  82. High alcohol consumption in Germany: results of the German National Health Interview and Examination Survey 19982004 · Crossref
  83. High Levels of Dietary Advanced Glycation End Products Transform Low-Dersity Lipoprotein Into a Potent Redox-Sensitive Mitogen-Activated Protein Kinase Stimulant in Diabetic Patients2004 · OpenAlex
  84. High mortality among young crack cocaine users in Brazil: a 5‐year follow‐up study2004 · Crossref
  85. High Off the Page2004 · Crossref
  86. High-Dose Methamphetamine Acutely Activates the Striatonigral Pathway to Increase Striatal Glutamate and Mediate Long-Term Dopamine Toxicity2004 · OpenAlex
  87. High-Risk Alcohol Consumption and Late-Life Alcohol Use Problems2004 · Crossref
  88. History of a Product and Its Production Techniques2004 · OpenAlex
  89. History of addictions2004 · OpenAlex
  90. HIV in injecting drug users in Asian countries2004 · OpenAlex
  91. HIV risk profile of male street youth involved in survival sex2004 · OpenAlex
  92. HIV Seroprevalence Among Homeless and Marginally Housed Adults in San Francisco2004 · OpenAlex
  93. Hormonal responses during prolonged exercise are influenced by a selective DA/NA reuptake inhibitor2004 · OpenAlex
  94. Households contaminated by environmental tobacco smoke: sources of infant exposures2004 · OpenAlex
  95. Housing First, Consumer Choice, and Harm Reduction for Homeless Individuals With a Dual Diagnosis2004 · Crossref
  96. How all Stars Works: An Examination of Program Effects on Mediating Variables2004 · OpenAlex
  97. How can we increase the involvement of primary health care in the treatment of tobacco dependence? A meta‐analysis2004 · Crossref
  98. How do drug users define their progress in harm reduction programs? Qualitative research to develop user-generated outcomes2004 · Crossref
  99. How have smoking risk factors changed with recent declines in California adolescent smoking?2004 · Crossref
  100. How much downside? Quantifying the relative harm from tobacco taxation2004 · Crossref